Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
AstraZeneca
QuintilesIMS
Mallinckrodt
Argus Health
Fuji
Merck
Fish and Richardson
Boehringer Ingelheim

Generated: June 25, 2018

DrugPatentWatch Database Preview

VANTAS Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Vantas patents expire, and when can generic versions of Vantas launch?

Vantas is a drug marketed by Endo Pharm and is included in one NDA.

The generic ingredient in VANTAS is histrelin acetate. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the histrelin acetate profile page.
Drug patent expirations by year for VANTAS
Synonyms for VANTAS
((ImBl)-D-His(sub 6),Pro(sub 9)-NEt)LHRH
(2S)-N-[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1R)-1-[(1-benzylimidazol-4-yl)methyl]-2-[[(1S)-1-[[(1S)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidine-1-carbonyl]-4-guanidino-butyl]carbamoyl]-3-methyl-butyl]amino]-2-oxo-ethyl]amino]-1-[(
[(im-Bzl)-D-His(6),Pro(9)-NEt]-gonadotropin releasing hormone
[(im-Bzl)-D-His6,Pro9-NEt]-gonadotropin releasing hormone
220810-26-4
5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-1-benzyl-D-histidyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide
5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-1-benzyl-D-histidyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide--acetic acid (1/2)
5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-N(sup tau)-benzyl-D-histidyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide
5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-N(tau)-benzyl-D-histidyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide
5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-Ntau-benzyl-D-histidyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide
712H828
76712-82-8
767H828
8148AH
ABP000581
AKOS030573448
AN-36908
BRN 4290557
C15H18N2O.CH4
C66H86N18O12
C66H86N18O12.C2H4O2
CHEBI:5739
CHEBI:63530
CHEMBL1200509
CHEMBL1201255
D02116
D02369
D0O7DG
DB06788
DTXSID30176580
DTXSID50227543
FT-0630849
GTPL3884
H50H3S3W74
histrelin
Histrelin (USAN/INN)
Histrelin [USAN:INN]
Histrelin acetate
Histrelin Acetate(Vantas)/
Histrelina
Histrelina [Spanish]
Histreline
Histreline [French]
Histrelinum
Histrelinum [Latin]
HSDB 7657
K321
L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-N(im)-benzyl-histidyl-L-leucyl-L-arginyl-L-proline ethylamide
L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-Nim-benzyl-histidyl-L-leucyl-L-arginyl-L-proline ethylamide
LS-186654
LS-88250
Luteinizing hormone-releasing factor (pig), 6-(1-(phenylmethyl)-D-histidine)-9-(N-ethyl-L-prolinamide)-10-deglycinamide-
Luteinizing hormone-releasing factor, 6-(1-(phenylmethyl)-D-histidine)-9-(N-ethyl-L-prolinamide)-10-deglycinamide-
NCGC00181758-01
ORF 17070
ORF-17070
QMG7HLD1ZE
RWJ 17070
RWJ-17070
SCHEMBL17881
SCHEMBL18715
SCHEMBL19409305
SCHEMBL19459949
SCHEMBL19712198
Supprelin
Supprelin (TN)
Supprelin LA
Suprellin
Suprellin LA
UNII-H50H3S3W74
UNII-QMG7HLD1ZE
Vantaas

US Patents and Regulatory Information for VANTAS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Endo Pharm VANTAS histrelin acetate IMPLANT;SUBCUTANEOUS 021732-001 Oct 12, 2004 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for VANTAS

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Endo Pharm VANTAS histrelin acetate IMPLANT;SUBCUTANEOUS 021732-001 Oct 12, 2004 ➤ Sign Up ➤ Sign Up
Endo Pharm VANTAS histrelin acetate IMPLANT;SUBCUTANEOUS 021732-001 Oct 12, 2004 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
McKinsey
Citi
UBS
Covington
US Army
Baxter
Daiichi Sankyo
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.